PLASMA PROTEIN BINDING OF DRUGS

被引:37
作者
KRIEGLSTEIN, J
机构
来源
KLINISCHE WOCHENSCHRIFT | 1969年 / 47卷 / 21期
关键词
D O I
10.1007/BF01483741
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1. Equilibrium dialysis, ultracentrifugation, and gel filtration on Sephadex are pointed out as being the most commonly used methods of quantitative determination of drug protein binding. 2. The interaction between proteins and substances of low molecular weight is governed by the law of mass action. It is the basis for the description of the results of binding experiments. The plotting of the data according to Scatchard (1949) is considered the most useful method. Also methods of plotting described by Scholtan (1962) and Krüger-Thiemer (1961) are used and offer advantages for special problems. 3. The binding of drugs to plasma proteins seems to take place mainly by hydrophobic mechanisms. The aromatic rings of the drugs apparently play an important part in their binding to proteins. 4. The bound drugs influence the structure of the proteins. 5. The binding of drugs to plasma proteins influences their action, tissue distribution, metabolism, and renal elimination. 6. The drug binding ability of plasma proteins can be changed in pathologic conditions. 7. Drugs can displace other drugs or physiological substances of low molecular weight from their binding sites on plasma proteins. © 1969 Springer-Verlag.
引用
收藏
页码:1125 / +
页数:1
相关论文
共 93 条
[11]   DISPLACEMENT OF 1 DRUG BY ANOTHER FROM CARRIER OR RECEPTOR SITES [J].
BRODIE, BB .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1965, 58 (11P2) :946-+
[12]   SOME PHYSICO-CHEMICAL FACTORS IN DRUG ACTION [J].
BRODIE, BB ;
HOGBEN, CAM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1957, 9 (06) :345-380
[13]  
BRODIE BB, 1964, ABSORPTION DISTRIBUT
[14]  
BUENGER P, 1961, ARZNEIMITTEL-FORSCH, V11, P726
[15]  
BUETTNER H, 1961, ARZNEIMITTELFORSCH, V11, P1133
[16]   ZUR PHARMAKOKINETIK VON SULFONAMIDEN UNTER PATHOLOGISCHEN BEDINGUNGEN [J].
BUTTNER, H ;
STAUDT, N ;
PORTWICH, F ;
MANZKE, E .
KLINISCHE WOCHENSCHRIFT, 1964, 42 (02) :103-&
[17]  
CHANG YH, 1967, BIOCHEM PHARMACOL, V16, P2053
[18]  
CHRISTENSEN LK, 1963, LANCET, V2, P1298
[19]  
DASTUGUE G, 1961, Therapie, V16, P804
[20]   MEASUREMENT OF BINDING CAPACITY OF CORTICOSTEROID-BINDING GLOBULIN IN HUMAN PLASMA [J].
DAUGHADAY, WH ;
ADLER, RE ;
RASINSKI, DC ;
MARIZ, IK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1962, 22 (07) :704-+